Grading (tumors)

Revision as of 16:27, 22 August 2015 by Jyostna Chouturi (talk | contribs)
(diff) ← Older revision | Latest revision (diff) | Newer revision → (diff)
Jump to navigation Jump to search

WikiDoc Resources for Grading (tumors)

Articles

Most recent articles on Grading (tumors)

Most cited articles on Grading (tumors)

Review articles on Grading (tumors)

Articles on Grading (tumors) in N Eng J Med, Lancet, BMJ

Media

Powerpoint slides on Grading (tumors)

Images of Grading (tumors)

Photos of Grading (tumors)

Podcasts & MP3s on Grading (tumors)

Videos on Grading (tumors)

Evidence Based Medicine

Cochrane Collaboration on Grading (tumors)

Bandolier on Grading (tumors)

TRIP on Grading (tumors)

Clinical Trials

Ongoing Trials on Grading (tumors) at Clinical Trials.gov

Trial results on Grading (tumors)

Clinical Trials on Grading (tumors) at Google

Guidelines / Policies / Govt

US National Guidelines Clearinghouse on Grading (tumors)

NICE Guidance on Grading (tumors)

NHS PRODIGY Guidance

FDA on Grading (tumors)

CDC on Grading (tumors)

Books

Books on Grading (tumors)

News

Grading (tumors) in the news

Be alerted to news on Grading (tumors)

News trends on Grading (tumors)

Commentary

Blogs on Grading (tumors)

Definitions

Definitions of Grading (tumors)

Patient Resources / Community

Patient resources on Grading (tumors)

Discussion groups on Grading (tumors)

Patient Handouts on Grading (tumors)

Directions to Hospitals Treating Grading (tumors)

Risk calculators and risk factors for Grading (tumors)

Healthcare Provider Resources

Symptoms of Grading (tumors)

Causes & Risk Factors for Grading (tumors)

Diagnostic studies for Grading (tumors)

Treatment of Grading (tumors)

Continuing Medical Education (CME)

CME Programs on Grading (tumors)

International

Grading (tumors) en Espanol

Grading (tumors) en Francais

Business

Grading (tumors) in the Marketplace

Patents on Grading (tumors)

Experimental / Informatics

List of terms related to Grading (tumors)

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]

Overview

In pathology, grading is a measure of the progress of tumors and other neoplasms. Some pathology grading systems apply only to malignant neoplasms (cancer); others apply also to benign neoplasms.

Pathology grading systems are used to classify neoplasms in terms of how abnormal the cells appear microscopically and what may be the outcome in terms of rate of growth, invasiveness, and dissemination. Cancer is a disorder of excessive cell growth, hence cancer cells often are poorly differentiated. The grade reflects the degree of cellular differentiation and refers to how much the tumor cells resemble or differ from the normal cells of the same tissue type.

An important part of evaluating a cancer is to determine its histologic grade. Grade is a marker of how differentiated a cell is. Grade is rated numerically (Grade 1-4) or descriptively (e.g., "high grade" or "low grade"). The higher the numeric grade, the more "poorly differentiated" is the cell, and it is called "high grade". A low grade cancer has a low number and is "well-differentiated." Grade is most commonly given on a three-tier scale. A cancer that is very poorly differentiated is called anaplastic. Tumors may be graded on four-tier, three-tier, or two-tier scales, depending on the institution and the tumor type.

The most commonly used system of grading is as per the guidelines of the American Joint Commission on Cancer. As per their standards, the following are the grading categories.

  • GX Grade cannot be assessed
  • G1 Well differentiated (Low grade)
  • G2 Moderately differentiated (Intermediate grade)
  • G3 Poorly differentiated (High grade)
  • G4 Undifferentiated (High grade)

Grading systems are also different for each type of cancer.

The Gleason system used to grade the adenocarcinoma cells in prostate cancer is the most famous. This system uses a grading score ranging from 2 to 10. Lower Gleason scores describe well-differentiated less aggressive tumours. Other systems include the Bloom-Richardson system (breast cancer) and the Fuhrman system (kidney cancer).

The tumor grade, along with the staging, is used to develop an individual treatment plan and to predict the patient's prognosis.

Examples of grading schemes

Four-tier grading scheme
Grade 1 Low grade Well-differentiated
Grade 2 Intermediate grade Moderately-differentiated
Grade 3 High grade Poorly-differentiated
Grade 4 Anaplastic Anaplastic
Three-tier grading scheme
Grade 1 Low grade Well-differentiated
Grade 2 Intermediate grade
Grade 3 High grade Poorly-differentiated
Two-tier grading scheme
Grade 1 Low grade Well-differentiated
Grade 2 High grade Poorly-differentiated

Related chapters

Resources

Template:Tumors

de:Grading

Template:WikiDoc Sources